Novavax, Inc. (NVAX)
8.295
-0.68
(-7.53%)
USD |
NASDAQ |
Feb 12, 15:28
Novavax Market Cap : 1.348B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 299.36B |
| Pfizer Inc. | 158.01B |
| Moderna, Inc. | 15.44B |
| Plus Therapeutics, Inc. | 36.53M |
| INVO Fertility, Inc. | 16.34M |
Market Cap Related Metrics
| PE Ratio | 4.690 |
| PS Ratio | 1.320 |
| Price | 8.295 |
| Earnings Yield | 21.32% |
| Operating PE Ratio | 3.371 |
| Normalized PE Ratio | 3.512 |